Delivery Order SPE2DB22D1106-SPE2DB24FFET0
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 5-160 MG TABLET 30S. The firm-fixed-price contract has a ceiling value of $3,103.17 and a period of performance through August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,840.67 contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a $1,155.95 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the provision of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of March 14, 2024 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating it was competitively bid. AmerisourceBergen holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,089.05 contract is for the provision of 4563783806 EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.10, is a Firm Fixed Price Delivery Order for the supply of EXFORGE 5-160 MG TABLET 30S. The contract has an ultimate completion date of January 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,023.95, is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through January 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
This federal contract award is a firm fixed price delivery order worth $3,255.22 granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a for-profit subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...